Axovant Gene Therapies Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share this article Share this article ResearchAndMarkets.com s offering. Report Highlights The Parkinson s Disease (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Parkinson s Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities/Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 3, 11, 48, 62, 4, 224, 97 and 9 respectively. Similarly, the Universities portfolio in Phase III, Phase II, Phase I, Preclinical and Discovery stages comprises 1, 1, 1, 52 and 19 molecules, respectively. The Parkinson s Disease (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter-strategies to gain competitive adva

Laura woodCavogene lifesciencesCorium incAddex therapeutics ltdCerecor incBiogen incCerevel therapeuticsCompanies in preAbbvie incChamishi therapeutics inc4d pharma plcBcworld pharm co ltdBrainstorm cell therapeutics incAppello pharmaceuticals incClene nanomedicine incCalifia bio inc